Gene: SLC51A
Official Full Name: solute carrier family 51 member Aprovided by HGNC
Gene Summary: Predicted to enable protein heterodimerization activity; protein homodimerization activity; and transmembrane transporter activity. Involved in bile acid secretion. Located in basolateral plasma membrane. Implicated in progressive familial intrahepatic cholestasis. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37807 | SLC51A Knockout cell line (HeLa) | Human | SLC51A | 1:3~1:6 | Negative | Online Inquiry |
KO37808 | SLC51A Knockout cell line (HCT 116) | Human | SLC51A | 1:2~1:4 | Negative | Online Inquiry |
KO37809 | SLC51A Knockout cell line (HEK293) | Human | SLC51A | 1:3~1:6 | Negative | Online Inquiry |
KO37810 | SLC51A Knockout cell line (A549) | Human | SLC51A | 1:3~1:4 | Negative | Online Inquiry |
SLC51A Gene Knockout Cell Lines are genetically engineered cell lines characterized by the targeted disruption of the SLC51A gene, which encodes for a vital protein involved in the absorption of bile acids and other amphipathic molecules. These knockout lines serve as crucial tools for elucidating the physiological roles of the SLC51A protein, particularly in metabolic and liver-related research.
The primary function of these cell lines lies in their ability to mimic and study the pathological states that arise from the dysfunction or absence of SLC51A. By providing a controlled environment that lacks this gene, researchers can thoroughly investigate the underlying mechanisms of bile acid transport, cellular metabolism, and their implications in diseases such as cholestasis and non-alcoholic fatty liver disease. With these models, scientists can explore the molecular pathways affected by SLC51A in situations of both health and disease.
From a scientific perspective, the availability of SLC51A Gene Knockout Cell Lines is significant for both basic research and clinical applications. They facilitate the exploration of drug interactions, toxicological assessments, and the efficacy of therapeutic agents targeting metabolic conditions. This product is particularly advantageous in preclinical studies where understanding the gene's mechanistic pathways can lead to better treatment strategies.
Compared to traditional methods, such as pharmacological inhibition, these knockout lines offer a more comprehensive and specific approach to study the SLC51A function without the confounding effects of off-target interactions, thereby providing results with increased reliability.
For researchers, clinicians, and pharmaceutical developers, SLC51A Gene Knockout Cell Lines represent an invaluable asset in advancing our understanding of liver physiology and pathophysiology, ultimately contributing to the development of targeted therapies. Our company, specializing in high-quality biological products, ensures a commitment to excellence and reliability, providing researchers with the vital tools they need for innovative scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.